價(jià)格 | ¥473 | ¥688 | ¥1230 |
包裝 | 1mg | 2mg | 5mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-12-12 |
中文名稱:化合物 Merafloxacin | 英文名稱:Merafloxacin |
CAS:91188-00-0 | 品牌: TargetMol |
產(chǎn)地: 美國(guó) | 保存條件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
純度規(guī)格: 97.57% | 產(chǎn)品類別: 抑制劑 |
貨號(hào): T9066 |
Name | Merafloxacin |
Description | Merafloxacin (CI 934) is a fluoroquinolone antibacterial, which was also identified as a 1 PRF inhibitor of SARS-CoV-2. |
In vitro | Frameshift inhibition by merafloxacin is robust to mutations within the pseudoknot region and is similarly effective on -1 PRF of other beta coronaviruses.?Importantly, frameshift inhibition by merafloxacin substantially impedes SARS-CoV-2 replication in Vero E6 cells, thereby providing the proof of principle of targeting -1 PRF as an effective antiviral strategy for SARS-CoV-2. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | H2O : Insoluble DMSO : < 1 mg/mL (insoluble or slightly soluble) |
Keywords | frameshifting | SARS-CoV | bacteria | antibacterial | fluoroquinolone | Inhibitor | CI-934 | gram-positive | Merafloxacin | inhibit | programmed | coronaviruses | CI934 | ribosomal | PRF | gram-negative | SARS coronavirus |
Inhibitors Related | Umifenovir hydrochloride | Imatinib | Chloroquine phosphate | Andrographolide | Hydroxychloroquine | EIDD-1931 | Chloroquine | Silymarin | Ritonavir | Nirmatrelvir | Favipiravir | Remdesivir |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 566.265100萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 天然產(chǎn)物,生化試劑,分子生物學(xué),分子砌塊,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP5年
|
山東沃德森生物科技有限公司
|
2025-02-12 | |
詢價(jià) |
VIP3年
|
湖北威德利化學(xué)試劑有限公司
|
2025-02-26 | |
詢價(jià) |
VIP1年
|
青島愷潤(rùn)生物醫(yī)藥科技有限公司
|
2025-02-07 |